1. Home
  2. Labeler Index
  3. Par Pharmaceutical, Inc.
  4. 42023-105
  5. NDC Package Code: 42023-105-01 Brevital Sodium

NDC Package 42023-105-01 Brevital Sodium

Methohexital Sodium Injection, Powder, Lyophilized, For Solution Intramuscular; - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
42023-105-01
Package Description:
1 VIAL in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product Code:
42023-105
Proprietary Name:
Brevital Sodium
Non-Proprietary Name:
Methohexital Sodium
Substance Name:
Methohexital Sodium
Usage Information:
BREVITAL can be used in adults as follows:1.For intravenous induction of anesthesia prior to the use of other general anesthetic agents.2.For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; BREVITAL may be given by infusion or intermittent injection.3.For use along with other parenteral agents, usually narcotic analgesics, to supplement subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for longer surgical procedures.4.As intravenous anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli (see WARNINGS).5.As an agent for inducing a hypnotic state.BREVITAL can be used in pediatric patients older than 1 month as follows:1.For rectal or intramuscular induction of anesthesia prior to the use of other general anesthetic agents.2.For rectal or intramuscular induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents for short surgical procedures.3.As rectal or intramuscular anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.
11-Digit NDC Billing Format:
42023010501
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1244233 - methohexital sodium Variable Concentration Multi-Use Injectable Solution
  • RxCUI: 1244233 - methohexital sodium 50 MG/ML Injectable Solution
  • RxCUI: 1244638 - Brevital Sodium Variable Concentration Multi-Use Injectable Solution
  • RxCUI: 1244638 - methohexital sodium 50 MG/ML Injectable Solution [Brevital]
  • RxCUI: 1244638 - Brevital 50 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Par Pharmaceutical, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Rectal - Administration to the rectum.
    • Active Ingredient(s):
  • METHOHEXITAL SODIUM 500 mg/1
    • Pharmacologic Class(es):
  • Barbiturate - [EPC] (Established Pharmacologic Class)
  • Barbiturates - [CS]
    • DEA Schedule:
    Schedule IV (CIV) Substances
    Sample Package:
    No
    FDA Application Number:
    NDA011559
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-01-2007
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 42023-105-01?

    The NDC Packaged Code 42023-105-01 is assigned to a package of 1 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial of Brevital Sodium, a human prescription drug labeled by Par Pharmaceutical, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular; intravenous; rectal form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 42023-105 included in the NDC Directory?

    Yes, Brevital Sodium with product code 42023-105 is active and included in the NDC Directory. The product was first marketed by Par Pharmaceutical, Inc. on November 01, 2007 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 42023-105-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 42023-105-01?

    The 11-digit format is 42023010501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-242023-105-015-4-242023-0105-01